3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
31
Recurrence
4
Neoplasms, Plasma Cell
3
Lymphoma
2
beta-Thalassemia
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multi-centric Castleman's Disease
1
Macular dystrophy, corneal type 1
1
Lymphoproliferative Disorders
1
Lymphoma, Mantle-Cell
1
Lymphadenopathy
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Immunoglobulin Light-chain Amyloidosis
1
HIV Infections
1
Carcinoma, Non-Small-Cell Lung
1
Anemia, Sickle Cell
1
Interventions
Specimen Handling
34
Carboplatin
32
pembrolizumab
28
Pemetrexed
27
Magnetic Resonance Spectroscopy
27
Cisplatin
22
Paclitaxel
15
Gemcitabine
13
durvalumab
12
Docetaxel
12
osimertinib
11
Nivolumab
11
atezolizumab
8
Immunoglobulin G
8
Disulfides
8
Taxes
7
Etoposide
7
130-nm albumin-bound paclitaxel
7
Radiotherapy
6
Radiosurgery
6
Radiation
6
Platinum
6
Cetuximab
6
Biopsy
6
X-Rays
5
1,2-diaminocyclohexaneplatinum II citrate
5
Ramucirumab
4
Observation
4
Irinotecan
4
Albumin-Bound Paclitaxel
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Bortezomib
×
30 days
×
Clear all
No trials found.